Estudy the Effect of Breast Cancer on Tlr2 Expression in Nb4 Cell by Amirfakhri, Siamak et al.
Asian Pacific Journal of Cancer Prevention, Vol 16, 2015 8445
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.18.8445
Breast Cancer Patient Serum and MCF-7 Cell-conditioned Medium Effects on Receptor Expression in NB4 Cells
Asian Pac J Cancer Prev, 16 (18), 8445-8450
Introduction
Breast cancer is the most common neoplasm in women 
and the most frequent cause of death in women between 
35 and 55 years of age. Various studies estimate the 5-year 
overall survival (OS) to be 65 %. Prognostic indicators 
include tumor size, axillary lymph node status, histological 
grade, tumor type, vascular invasion, and estrogen receptor 
status (Lee et al., 2002; Olewniczak et al., 2002). Several 
immunological markers of the disease have been reported, 
and recent developments in molecular and cytogenetic 
analysis have provided new means to evaluate prognosis 
(Giatromanolaki et al., 2002).
All multicellular organisms have an innate immune 
system, whereas the adaptive or ‘acquired’ immune system 
is restricted to vertebrates (Fearon and Locksley, 1996). 
The innate immunity system is comprised of physical 
barriers such as skin and mucosal linings of soluble 
factors such as complement components, chemokines and 
cytokines, and cells such as monocytes, macrophages, 
dendritic cells and polymorphonuclear blood cells 
(PMNs). Breaks in physical barriers such as a skin cut or 
severe burn can increase susceptibility to infection.
Pathogen associated molecular patterns (PAMPs) are 
conserved microbe-specific molecules that are associated 
with groups of pathogens. More precisely, PAMPs are 
small molecular motifs conserved within a class of 
microbes. Pathogen associated molecular patterns are 
recognized by Toll-like receptors (TLRs) and other 
pattern recognition receptors (PRRs) that are proteins 
expressed by cells of the innate immune system. Cluster 
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of differentiation 14 (CD14) (Fearon and Locksley, 1996; 
Medzhitov et al., 1997) and mannan-binding lectin (MBL) 
are the examples of these receptors.
TLR-bound PAMPs activate signal transduction 
pathways that result in the expression of specific genes that 
code for cytokines involved in immunological responses. 
To date, 13 TLRs have been identified, all possessing an 
intracellular domain similar to interleukin-1 (IL-1), that 
so-called TIR (toll-IL-1 receptor) domain too (Medzhitov 
et al., 1997).
It has been demonstrated that PAMP-mediated 
activation of phagocytic cells, such as monocyte-derived 
macrophages involves a cell-surface complex of CD14 
and TLRs (specifically TLR2). TLR2 recognize highly 
conserved structural motifs known as PAMPs, which are 
exclusively expressed by microbial pathogens (Underhill 
et al., 1999).
Neutrophils and Their Functions: Neutrophil is a 
particularly abundant PML type, comprising 50-60% 
of circulating leukocytes. They are the first line of 
defense against infection and injury. The life span of a 
terminally differentiated leukocyte in the blood stream 
is about 6-8 hours (Cassatella et al., 1997). However, 
neutrophils exposed to certain external stimuli such as 
interleukin-1β (IL-1β), IL-6, IL-8, TNF-α, GM-CSF, 
and oncostatin M (OSM), can survive for longer periods 
of time (Cross et al., 2003). The presence of neutrophils, 
found typically at sites of inflammation, infection, trauma 
and ischemia, is mostly beneficial. However, they have 
been implicated in cancer development and progression 
(Baggiolini et al., 1989). Since neutrophils are terminally 
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differentiated, they have little capacity for biosynthesis, 
but they can produce considerable amounts of cytokines 
(Cassatella, 1995) and chemokines (Scapini et al., 2000). 
Both are responsible for chemotaxis of effector cells, 
their activation and proper functioning. Neutrophils are 
among the first response elements to infiltrate an injured 
tissue where they produce TNFα (Feiken et al., 1995) 
and interleukins (IL-1α and IL-1β) (Hubner et al., 1996). 
These protein inflammatory messengers recruit leukocytes 
to the site of inflammation and mediate tissue repair by 
stimulating fibroblasts (Chedid et al., 1994) to produce 
matrix metalloproteinases (MMPs) and keratinocyte 
growth factor (KGF/FGF-7). Another important function 
of neutrophils is the production of oxidative radicals in 
the infected tissue and phagocytosis of infective agents 
(Kohen and Nyska, 2002).
Toll-like Receptors 2 (TLR2): Pattern recognition 
receptors (PRRs), comprise a diverse, evolutionary 
conserved set of proteins that recognize specific PAMPs. 
Thereby, PRRs allow the innate immune system to 
distinguish self-molecules from pathogen associated non-
self-structures and to initiate the host defense response 
(Medzhitov and Janeway, 1998; Janeway and Medzhitov, 
2002). PAMPs represent the molecular signatures of 
potentially noxious substances and may be perceived as 
a ‘danger signal’ (Medzhitov and Janeway, 1998) by the 
innate immune system (Janeway, 1989c; Janeway, 1989b; 
Janeway, 1989a; Fearon and Locksley, 1996).
TLRs are broadly expressed on macrophages, 
dendritic cells, epithelial cells, B-cells (TLR4 and 9) 
and T-cells (TLR2). TLRs are transmembrane proteins 
with an extracellular domain containing leucine-rich 
repeats that recognize conserved motifs on pathogens, 
and a cytoplasmic domain similar to the corresponding 
domain of the IL-1 receptor involved in signal transduction 
(Aderem and Ulevitch, 2000; Hallman et al., 2001). 
The capacity of TLRs to alter the phenotype of the cell 
on which they are expressed, makes them attractive 
candidates for the initiators of the entire program of host 
defense, be it innate or acquired.
The role of TLRs in the recognition of pathogens and 
the initiation of adaptive immune responses against them 
is well known. However, TLRs have been identified on 
several tumor cell types, including tumor cells of human 
malignancies (Zeromski et al., 2008). Their expression 
in cancer results either in promoting or inhibiting tumor 
progression. It has been demonstrated that several TLR 
agonists (natural and synthetic) may have a beneficial 
effect on tumor-mediated disease, leading to potentiation 
of the immune response to tumor-associated antigens.
TLR proteins can be used by the host to recognize and 
conserve PAMPs (So and Ouchi, 2010). However, some 
TLRs are able to detect specific host molecules, such as 
high-mobility group box protein 1 (HMGB1) and heat 
shock proteins (HSP), leading to inflammatory responses. 
Thus, it has been suggested that TLRs are involved in 
the development of many pathogenic conditions. Recent 
advances in TLR-related molecules have highlighted the 
therapeutic potential of these proteins against diseases, 
such as autoimmune disease and cancer.
TLR2 is found on the cell surface, but after activation 
it enters phagosomes (Janeway and Medzhitov, 2002). 
Self-antigens have been reported that can stimulate TLR2 
including heat shock protein 60 (HSP60) (Ohashi et al., 
2000), heat shock protein 70 (HSP70) and endoplasmin 
(Vabulas et al., 2002), which are components of the 
extracellular matrix (fibronectin) (Liu-Bryan et al., 2005).
Xie et al. (2009) reported invasion behavior by MDA-
MB-231 cells, mediated by TLR2 through activation of 
the nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-κB) pathway. TLR2 is expressed in MDA-
MB-231 cells at high levels and mediates aggressive cell 
invasion. As compared to other breast cancer cell lines, the 
MDA-MB-231 cell line produces 10 fold greater amounts 
of TLR2. One consequence is that, TLR2 activation 
leads to the secretion of growth and attachment factors 
including, IL-6, transforming growth factor beta (TGF-β) 
and vascular endothelial growth factor (VEGF) (Xie et al., 
2009). TLR2 and TLR9 have been reported to promote 
tumor invasive behavior via metalloproteases (Chen et al., 
2007) and integrins (Coussens and Werb, 2002).
TLR stimulation in vitro of several types of tumor 
cell lines leads to their enhanced survival and increased 
cell proliferation. Cells isolated from patients suffering 
from multiple myeloma expressed increased levels 
of TLR2 receptors. TLR ligands that are encoded by 
pathogens have been divided into three categories based 
on their chemical structure. TLR4 receptors recognize 
lipopolysaccharides (LPS) from Gram-negative bacteria, 
belong to the lipoprotein and lipid category (Akira et al., 
2006). There is evidence to indicate the over expression of 
TLRs in mouse (Huang et al., 2005) and in human prostate 
cancer, lung cancer, breast cancer and neuroblastoma. 
Different types of tumors have been reported to express 
a wide array of TLRs, but this has been correlated with 
increased cell survival, progression, tumor mass growth, 
metastasis and invasion of the cancer cells (Droemann et 
al., 2005; Hassan et al., 2006; Ilvesaro et al., 2007). TLR4 
expression in human breast cancer cells leads to immune 
escape of breast tumor cells and their metastasis and 
invasion to other parts of the body (Ilvesaro et al., 2007).
Materials and Methods
Cell line and cell culture
NB4 Cell Line: Acute promyelocytic leukemia (APL) 
is a well-defined sub-type of acute myelogenous leukemia, 
cytogenetically characterized by t (15; 17) (q22; q11-12) 
translocation. The cell line NB4 is the only permanent cell 
line with t (15; 17), and was established from the leukemia 
cells of a patient with APL. APL cells have a strikingly 
low proliferation potential in vitro. Mitotic cells are often 
scarcely detected after 3 to 4 days in culture. However, 
APL cells do survive in culture, while many leukemia cell 
types die. This suggests that they have no requirement for 
survival factors, unlike normal promyelocytes or factor-
dependent cell lines.
The NB4 cell line was used as a model for neutrophils 
in this project because NB4 cells have a myeloblastic 
morphology and lack typical APL granules. This finding 
does not necessarily contradict the promyelocytic nature 
of the leukemia, because hypogranular forms of APL have 
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been described (Lubbert and Koeffler, 1988).
Methods
Cell Culture: NB4 cells and MCF-7 cells were cultured 
in RPMI-1640 medium (PAA Laboratories Gmbh, Austria) 
containing 10 % FCS (PAA Laboratories Gmbh, Austria). 
Cells were cultured at 37°C in a humidified 5% CO2 
incubator. Staining immune system receptor in NB4 cells 
for flow cytometry analysis.
NB4 cells were stimulated with FCS, MCF-7 cell-
conditioned medium (prepared by culturing MCF-7 cells 
in RPMI-1640 medium). Positive controls comprised 
treating NB4 cells with 100 IU/ml of recombinant 
human interferon-gamma (rh IFN-γ) (Immuno Tools; 
CAT#11343536) and 1 µg/ml LPS 055:B5 from 
Escherichia coli (SIGMA; CAT#L4524). Cells were 
stained using fluorescein isothiocyanate (FITC), TLR2 
(Biolegend; CAT#325604). IgG isotype FITC mouse 
antibody (Biolegend; CAT#400212) was used as the 
negative control. Samples were then analyzed using a 
Aria generation 1 (BD Biosciences) system.
Western blots: The NB4 cells were stimulated with 
FCS, MCF-7 cell-conditioned medium, 100 IU/ml IFN-γ 
and 1 µg/ml LPS. To prepare whole cell lysate, Proteo 
JET™ Mammalian cell Lysis (Fernataz; CAT#K0301) 
and protease inhibitor (Sigma-Aldrich) were mixed at a 
100:1 ratio and added to NB4 cells. THP-1 cell lysate, 
used for analyzing TLR2 protein expression, served as 
positive controls.
For each cell line, 5×106 cells were lysed by incubation 
on ice with 400 µl sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) sample buffer. Lysates 
were centrifuged for 20,000 g at 4oC for 10 min, and 20 
µg of each protein samples were run on SDS-PAGE under 
reducing conditions. Proteins were electrotransferred to 
a nitrocellulose membrane and detected with a primary 
antibodies mouse anti-human TLR2. secondary antibody 
goat anti-mouse IgG IRDye 800CW (ODYSSEY; 
CAT#926-32210). The membrane was read using a Li-
Cor scanner using Odessy software. PageRuler™ Plus 
Prestained Protein Ladder from Fermentas (Thermo 
Fisher Scientific; CAT#26616) was used to estimate the 
molecular weight of the proteins. 
Results 
Intracellular Expression
A summary of the data obtained are shown in the bar 
charts of the expression of intracellular receptor in NB4 
cells cultured with FCS (A), MCF-7 cell-conditioned 
medium (B), IFN-γ and LPS (C) stained with FITC-
conjugated mouse-monoclonal antibodies specific for 
human TLR2. IgG isotype antibody used as negative 
control (Figure 1). These flow cytometer results show that 
TLR2 expression was up-regulated in NB4 cells incubated 
with MCF-7 cell-conditioned medium (B).
A) Expression of TLR2 receptor in NB4 cell cultured 
with FCS. B) Expression of TLR2 receptor in NB4 
cell cultured with MCF-7 cell-conditioned medium. C) 
Expression of TLR2 receptor in NB4 cell cultured with 
IFN-γ + LPS after 6 hours incubation. C is the positive 
control. Part A is the negative cells and part b is the 
positive cells.
Western Blotting
In order to detect the expression of TLR2 in NB4 cells 
by western blot, cell lysates were prepared from NB4 cells 
incubated with FCS, MCF-7 cell-conditioned medium, 
IFN-γ and LPS, and then separated on 12% SDS-PAGE 
(Figure 2).
1) Protein ladder, 2) NB4 cells stimulated with MCF-7 
cell-conditioned medium, 3) NB4 cells stimulated with 
10 % concentration of FCS, 4) NB4 cells stimulated with 
100 IU/ml IFN-γ +1 µg/ml LPS, 5) THP-1 cell lysate as 
positive control. All stimulations were done for 6 hours. 
TLR2 detected at its expected molecular weight 90-100 
kDa.
Figure 2. Western Blotting of TLR2 Receptor in NB4 
Cells Lysate
Figure 1. Intracellular expression of TLR2 receptor 
in NB4 cell cultured with FCS (untreated negative 
control), MCF-7 cell-conditioned medium or 100 
IU/ml IFN-γ+1 µg/ml LPS (treated positive control) 
confirmed by flow cytometry. Black filled histograms 
show Isotype Control, and yellow filled histograms represent 
mean IMF intensity of NB4 cells labelled with FITC antibodies
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Discussion
This study has focused on the effect of conditioned 
medium isolated from cultured breast cancer cells on 
NB4 neutrophil-like cells. Intracellular immune receptor 
was examined. The human promyelocytic cell line NB4 
was used as a model system as it is an easily accessible 
cell type that propagates in vitro. This cell line has been 
previously used as it closely resembles the phenotype of 
real neutrophils from normal adults. NB4 cells exhibit the 
chromosomal translocation t (15; 17), specific for acute 
promyelocytic leukemia (APL) that results in the fusion 
of the retinoic acid receptor alpha (RARA) gene to the 
promyelocytic leukemia (PML) gene. The characterization 
of PML is a putative zinc finger protein and potential 
transcription factor, with at least three transcription 
products (Goddard et al., 1991). In the current study 
presented here it was hypothesized that patients suffering 
from breast cancer have a stimulated immune system and 
hence trigger the release of soluble proteins that alters the 
phenotype of cells including neutrophils and granulocytes. 
If so, it is likely that some of those soluble proteins would 
up-regulate or down-modulate immune receptors. This 
effect can be local at the site of a tumor or at systemic 
level. In previous studies it has been shown that secretion 
of cytokines released into the circulation and present in 
the plasma could lead to systemic activation of immune 
receptors and hence affects host tumor interactions 
(Silverman et al., 2005).
Conditioned medium is the general term used to 
describe complete medium fluid in which cells have 
been cultured for a period of time. Conditioned media 
are obtained from short-term or long-term cultures of the 
cancer cells, which are likely to contain different soluble 
mediators or secreted factors. These mediators include 
metabolites such as glucose, amino acids, and nucleosides; 
growth factors such as interleukins, epidermal growth 
factor (EGF), and platelet-derived growth factor (PDGF); 
and matrix proteins such as collagen, fibronectin and 
cytokines. Collectively, these products are likely to have 
a strong influence on the cancer cells and may promote 
either the growth or inhibition of neoplasma cells and 
metastasis.
In normal healthy individuals neutrophils are able to 
attach and eliminate microorganisms with the release of 
cytotoxic substances (Smith, 1994). Activated neutrophils 
also release proteinases into the extracellular environment, 
directing to damage of surrounding host tissue (Pham, 
2006). Moreover, neutrophils produce cytokines and 
chemokines, which contribute to inflammation and cell 
recruitment and thus modifies the immune response 
(Nathan, 2006). This process of PMN recruitment and 
activation, found in during infection, is enhanced within 
the tumor microenvironment. In this context, PMNs could 
act to the damage of the host cells.
Previous studies have shown that a factor present 
in the conditioned media obtained from hepatocellular 
carcinoma cells induced the production of hepatocyte 
growth factor (HGF) from neutrophils, which promoted 
increased invasiveness by the tumor cells (Imai et al., 
2005). These authors suggest that, although neutrophils 
release a paucity of cytokine in contrast to macrophages 
and other cells within the tumor microenvironment, the 
temporal-spatial contribution of these substances by PMN 
performs unique roles in tumor progression.
In the current study neutrophil-like NB4 cells were 
incubated with MCF-7 cell-conditioned medium. 
After 6 h incubation the receptor TLR2, was analyzed 
as intracellular on NB4 cells. These molecules were 
investigated in NB4 cells. The results revealed that 
MCF-7 cell-conditioned medium elicited the expression 
of TLR2 in NB4 cells. This observation is of utmost 
significance as it is known that TLRs are considered 
important innate recognition molecules of the immune 
system. Their role in the recognition of pathogens and the 
initiation of adaptive immune responses well established. 
TLRs have been previously reported on several tumor 
cells (Sato et al., 2009). Activation of TLRs with their 
ligands directly or with aid of accessory proteins such as 
CD14 and MD2 (in the case of TLR2 and TLR4), cells 
evoke strong inflammatory responses. This mechanism is 
capable of coordinating the immune system in the whole 
organism, protecting the host from pathogen spreading 
after infection (Takeda and Akira, 2005). In this context 
it was reported that TLR expression in many tumors or 
cell lines is inducible and hence likely to play an anti-
tumor effect (Yu and Chen, 2008). Also, in some tumor 
models, polymorphism of TLR2 and TLR4 is known to 
be a contributory factor to the risk of cancer. This implies 
that genetic variation or alleclic forms of TLR may be 
connected with specific tumor progression (El-Omar et 
al., 2008). In the current study it is shown that TLR2 
is affected by MCF-7 cell-conditioned medium in the 
cytoplasm of NB4 cells.
TLR2 is the receptor for several microbial ligands, 
including gram-positive bacteria, peptidoglycan, yeast 
zymosan, and mycobacterial lipoarabinomannan (LAM) 
(Means et al., 2000; Zhang and Ghosh, 2001). On the other 
hand TLR4 is the receptor for gram-negative bacteria, 
LPS, and some viruses (Means et al., 2000; Zhang and 
Ghosh, 2001; Kurt-Jones et al., 2002). The receptors 
TLR2 and TLR4, like other TLR group members, have a 
conserved intracellular signaling motif also found in the 
intracellular domain of the IL-1 receptor. This motif is 
responsible for NF-κB activation/translocation after TLR 
or IL-1 receptor engagement. It is also a crucial signaling 
pathway for IL-1β and TNF-α secretion (O’Neill, 2000).
 Intracellular Receptor Expression in NB4 Cells: The 
experiments for this study were carried out by incubating 
NB4 cells at 37 °C for a maximum period of 6 h with 10 % 
FCS, the breast cancer cell line MCF-7. It was anticipated 
that this treatment would result in the production of 
particular stimulants (i.e. soluble cytokines), eliciting the 
expression of immune system receptors. However, the 
flow cytometry results demonstrated that MCF-7 cell-
conditioned medium elicited an effect on TLR2 receptors 
as intracellular receptor. A reasonable hypothesis is to 
as same that the patient with cancer have a stimulated 
immune system if so it is likely but immunological 
receptors as well as cytokines are expressional locally at 
the site of cancer systemically. There for the reasonably 
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as submission is to expect the present function of soluble 
cytokine which stimulate the biological receptors of 
immune system.
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